Nautilus Biotechnolgy (NAUT) Ownership - Who owns Nautilus Biotechnolgy?
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NAUT showed earnings on July 31, 2025. You can read more about the earnings report here.